156 related articles for article (PubMed ID: 17180944)
1. [Biochemical markers of bone formation in hemodialysis and after allotransplantation of cadaveric kidney].
Ermakova IP; Pronchenko IA; Buzulina VP; Nikonova TIu; Borisova AV
Ter Arkh; 2006; 78(10):73-6. PubMed ID: 17180944
[TBL] [Abstract][Full Text] [Related]
2. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
3. Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover.
Alvarez L; Torregrosa JV; Peris P; Monegal A; Bedini JL; Martinez De Osaba MJ; Filella X; Martin G; Ricos C; Oppenheimer F; Ballesta AM
J Bone Miner Metab; 2004; 22(3):254-9. PubMed ID: 15108068
[TBL] [Abstract][Full Text] [Related]
4. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
5. [Hormonal activity of the hypophysial-gonadal axis versus the mineral bone density and specific markers of bone turnover in haemodialysis population].
Kurnatowska I; Zygmunt A; Fijałkowska-Morawska J; Białkowska J; Jabłkowski M; Nowicki M; Lewiński A
Pol Merkur Lekarski; 2006 Apr; 20(118):408-12. PubMed ID: 16886562
[TBL] [Abstract][Full Text] [Related]
6. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
[TBL] [Abstract][Full Text] [Related]
7. [Biochemical markers of bone metabolism and bone tissue losses after allotransplantation of the cadaveric kidney: a cross-sectional].
Pronchenko IA; Buzulina VP; Tomolina NA; Vedernikova RN; Ermakova IP
Klin Lab Diagn; 2005 Nov; (11):3-8. PubMed ID: 16404967
[TBL] [Abstract][Full Text] [Related]
8. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
[TBL] [Abstract][Full Text] [Related]
9. [Early, noninvasive diagnostic of osteoporosis in men].
Lepiarz-Rusek W; Kokocińska D
Przegl Lek; 2005; 62(7):641-9. PubMed ID: 16463693
[TBL] [Abstract][Full Text] [Related]
10. [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria].
Ambroszkiewicz J; Gajewska J; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Nowacka M; Milanowski A
Pol Merkur Lekarski; 2008 Jul; 25(145):57-60. PubMed ID: 18839616
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y
Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
[TBL] [Abstract][Full Text] [Related]
14. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
Koizumi M; Yonese J; Fukui I; Ogata E
J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in kidney transplant recipients and patients on hemodialysis: a comparison with healthy individuals.
Nouri-Majalan N; Sanadgol H; Rahimian M; Soleimani H
Iran J Kidney Dis; 2008 Jul; 2(3):154-9. PubMed ID: 19377230
[TBL] [Abstract][Full Text] [Related]
16. Bone loss in pediatric renal transplant recipients.
el-Husseini AA; el-Agroudy AE; Sobh MA; Ghoneim MA
Nefrologia; 2003; 23 Suppl 2():131-4. PubMed ID: 12778870
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
Okuno S; Inaba M; Kitatani K; Ishimura E; Yamakawa T; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy.
Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N
Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Jono S; Miki T; Inaba M; Nishizawa Y
Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
